Found 7 matching trials
The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS
PHASE3SIM0308-302 is a multicenter, randomized, double-blind, placebo-controlled ...
Location
Multiple Locations
Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study
PHASE4Chemotherapy-induced cognitive impairment (CICI), also known as "chemobrain...
Location
The First Affiliated Hospital of China Medical University
Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS)
PHASE4This is a multicenter, randomized, double-blind, placebo-controlled clinica...
Location
Xinqiao Hospital and The Second Affiliated Hospital
Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
PHASE2This is a multicenter, randomized, double-blind, placebo-controlled, explor...
Location
Taihe County People's Hospital
Edaravone Dexborneol for Post-Stroke Epilepsy
PHASE3This is a prospective, randomized, double-blind, placebo-controlled, multic...
Location
The First Affiliated Hospital of Wenzhou Medical University
Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease
PHASE3This study is a multicenter, randomized, double-blind, placebo-controlled t...
Location
Peking Union Medical College Hospital
Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL
PHASE2This study is a single-center, prospective, single-arm, self-controlled cli...
Location
Huashan Hospital, Fudan University